Asupardo, Ricthel .
HRN: 23-60-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/28/2024
02/04/2024
IV
2.25
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes